(Total Views: 470)
Posted On: 05/24/2019 9:59:34 AM
Post# of 154868
I knew RP was extremely confident in our cancer outcome, but wasn’t aware he stated 90% (the Emerging Growth article also stated 90%). I do trust his expertise especially give his background with cancers and CCR5.
When I was previously looking it was because the stock didn’t move based on the preclinical results. I get it they are mice, but such compelling results I thought surely have a decent chance in humans. If these were the results of a larger company with analysts coverage some of them would likely give a fractional credit of success and thus impacting the share price a little. This will change once injection happens and we get interim results.
As always, thanks for the additional info and have a great weekend!
When I was previously looking it was because the stock didn’t move based on the preclinical results. I get it they are mice, but such compelling results I thought surely have a decent chance in humans. If these were the results of a larger company with analysts coverage some of them would likely give a fractional credit of success and thus impacting the share price a little. This will change once injection happens and we get interim results.
As always, thanks for the additional info and have a great weekend!
(1)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
